BSE filing, NSE: ACFSL. Summary written from the filing by ALFA Finder's alert engine.
Amrapali Capital & Finance Services Ltd: key numbers
- Share price
- ₹83.10
- Market cap
- ₹81.26 Cr
- Revenue (annual)
- ₹8,270 Cr
- Net profit (annual)
- ₹4.86 Cr
- P/E (TTM)
- 16.7×Sector 19.7×
- Promoter holding
- 64.66%
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Amrapali Capital & Finance Services Ltd
All →Amrapali Capital & Finance Services Annual General Meeting
Amrapali Capital and Finance Services Ltd. held its 32nd Annual General Meeting on September 29, 2026, where shareholders adopted financial statements and approved director re-appointments.
Amrapali Capital & Finance Services Management Change
Amrapali Capital and Finance Services Limited announced the re-appointment of Alkesh Patel as Executive Director and Bhumiben Atitbhai Patel as Non-Executive Independent Director.
Amrapali Capital & Finance Services Annual Report
Amrapali Capital and Finance Services Ltd has filed its Annual Report for the financial year 2025-26 with the BSE.
Amrapali Capital & Finance Services Annual General Meeting
Amrapali Capital and Finance Services Ltd. has issued a notice for its 32nd Annual General Meeting to be held on September 29, 2026.
Amrapali Capital & Finance Services Board Meeting Outcome
Amrapali Capital and Finance Services Ltd. approved its Board Report, the re-appointment of its Chairman & MD, and an Independent Director during its board meeting.
Amrapali Capital & Finance Services Management Change
Company Secretary and Compliance Officer Mr. Harimohan Namdev resigned, and Ms. Priya Kshtriya has been appointed to the position.
Other other announcement announcements
All →eMudhra Other Announcement
eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.